Dysplasia is a very imperfect biomarker for malignancy in Barrett's esophagus. Invasive
cancer has been found in 30–40% of esophagi resected because preoperative endoscopic …

Endoscopic mucosal resection (EMR), which is advocated for the treatment of early
(superficial) gastroesophageal neoplasms, has also been alluded to represent a superior …

Endoscopic mucosal resection (EMR), a relatively new endoluminal therapeutic technique
with low morbidity and no mortality reported to date, is advocated for the treatment of …

Background: Barrett's esophagus is thought to be the result of long-standing
gastroesophageal reflux disease and is known to be the most important risk factor for the …

Background Endoscopic ultrasound (EUS) is useful for detecting depth of invasion and
nodal involvement in patients with early Barrett's neoplasia (EBN), precluding endoscopic …

Endoscopic mucosal resection (EMR), or mucosectomy, represents a major therapeutic
advance in the management of gastrointestinal (GI) malignancy. First introduced in Japan …

Scotiniotis et al. studied the accuracy of conventional EUS (7.5±12 MHz) in the evaluation of
BE with HGD or ICA in 22 patients [20]. The sensitivity and specificity of EUS for detecting …

Endoscopic ablative therapies, including photodynamic therapy and argon plasma
coagulation, have been used successfully for HGIN in Barrett's esophagus [16±17]. The …

Barrett 食管(Barrett's esophagus, BE) 是食管下段的复层鳞状上皮被单层柱状上皮替代的一种
病理现象. 其长度> 3cm 称为长段BE (Long—segment BE, LSBE),< 3cm 称短段BE (Short …

Barrett's esophagus (BE) is a well-established premalignant condition that entails a 30-to 50-
fold greater risk for development of esophageal adenocarcinoma (EAC) with an estimated …